Company: IMG
Filing Date: 2025-07-18
Form Type: 8-K
Source: 0001641172-25-020226
Chunk: 0

Company: CIMG Inc.
Filing Date: 2025-07-18
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item
3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

Nasdaq
Delist Determination Letter

On
July 17, 2025, CIMG Inc. (Nasdaq: IMG) (the “ Company”) received an additional delist determination letter from Nasdaq (“ Nasdaq
Delist Determination Letter”).

On
January 14, 2025, Nasdaq notified the Company that the bid price of its listed security had closed at less than $1 per share over the
previous 30 consecutive business days, and, as a result, did not comply with Listing Rule 5550(a)(2) (the “ Rule”). In accordance
with Listing Rule 5810(c)(3)(A), the Company was provided 180 calendar days, or until July 14, 2025, to regain compliance with the Rule.

The
Company has not regained compliance with the Rule and is not eligible for a second 180-day period, primarily because
the Company does not comply with the initial listing requirements for The Nasdaq Capital Market under the Equity Standard or the alternative
standards. According to the Nasdaq Delist Determination Letter, this matter serves as an additional basis for delisting the Company’s
securities from The Nasdaq Stock Market.

On
July 7, 2025, the Company appealed the Nasdaq delist determination letter dated June 27, 2025, and the Nasdaq Hearings Panel (the “ Panel”)
has scheduled a hearing for the appeal on August 14, 2025.

Nasdaq
notified the Company that the Panel will consider this matter in rendering a determination regarding the Company’s continued listing
on The Nasdaq Capital Market. Pursuant to Listing Rule 5810(d), the Company should present its views with respect to this additional
deficiency at its Panel hearing.

The
Company is actively addressing the deficiencies noted in the Nasdaq delist determination letters dated June 17, 2025, and July 17, 2025,
and is diligently preparing for the hearing on August 14, 2025.

Item
9.01 Financial Statement and Exhibits